Committed to Healthcare & Healthcare Professionals
Discover AptusCompany overview
Built on quality.Growing with purpose.
Aptus Pharma Ltd., established in 2010, is a fast-growing player in India's pharmaceutical sector, driven by a strong focus on brand building and market expansion. The company is engaged in developing and promoting high-quality pharmaceutical brands across diverse therapeutic segments, earning trust among healthcare professionals and consumers.
Aptus offers a diversified portfolio of formulations spanning chronic, acute, and wellness segments. Its business is strategically structured across key verticals: the Pharma Formulation Vertical, which drives core revenues through prescription-based therapies and strong doctor engagement; the OTC Vertical, focused on consumer healthcare and wellness products; and the Global Vertical, which expands international reach while contributing to revenue through exports and related service income.
As a Public Limited Company listed on the BSE SME platform, Aptus Pharma Ltd. continues to strengthen its position with a vision of delivering accessible, affordable, and high-quality healthcare solutions while driving sustainable and scalable growth.
Our business verticals
Our Core Values
Quality
We commit to delivering the highest quality products and services.
Commitment
We exceed expectations and achieve goals with unwavering dedication and passion.
Hardwork
Our relentless pursuit of excellence drives tireless effort and innovation.
Trustworthiness
We build strong relationships with stakeholders on a foundation of integrity and transparency.
Core purpose
We deliver quality and innovation to redefine human lives.
Brand promise
Committed to Healthcare & Healthcare Professionals
Aptus Pharma pledges to uphold the highest standards in contributing to the well-being of individuals and supporting the healthcare community.

Journey
Key milestones.

2010
Incorporation of Aptus Pharma Limited
- Company incorporated with a vision to provide affordable and high-quality pharmaceutical products to improve healthcare outcomes

2011–2016
Early growth phase
- Started operations with 11 products across 5 therapeutic categories
- Expanded portfolio to 50+ products

2016–2020
Portfolio & footprint expansion
- Strengthened acute therapy portfolio and added new molecules
- Expanded distribution footprint and established operational systems

2021–2025
Scaling & strengthening
- Product portfolio expanded to 175+ products
- Entered OTC & Wellness categories
- Strengthened multiple business divisions
- Expanded presence into West Bengal and Ahmedabad

2025–2026
Listed on BSE SME Platform
- Strengthening governance, transparency and credibility to support the next phase of growth.
- Future ready: expanding the formulation portfolio.
- Future ready: strengthening Rx, OTC, Global & Orbit verticals.
Our journey continues
Driven by trust, innovation and execution, we are committed to building a stronger, broader and more impactful healthcare platform.

Manufacturing & quality control
At Aptus Quality is a Habit, Not an Act.
The Company follows an asset-light contract manufacturing model and does not own manufacturing facilities. It has entered into contractual manufacturing arrangements with WHO-GMP-certified manufacturing units under various arrangements.
Manufacturing partners
The Company has formal loan and licence agreements with manufacturing units in Gujarat, while additional products are manufactured through other WHO-GMP-compliant manufacturing partners based on purchase orders (POs). This model enables the Company to maintain stringent quality standards while ensuring flexibility, scalability and efficient production.
Every batch evaluated
At Aptus Pharma Ltd., every batch undergoes stringent quality evaluation to ensure safety, efficacy, and compliance with global standards.
Quality tests
- Assay of Active Pharmaceutical Ingredients (API)
- Dissolution & Disintegration Profile
- Uniformity of Content (UOC)
- Related Substances Compliance
- Impurity Profiling
- Tablet/Capsule Hardness Test
- pH Level Evaluation
- Microbiological Analysis
- Friability Testing
- Karl Fischer (KF test)
- Diethylene glycol (DEG) and ethylene glycol (EG) Test
Leading brands
A portfolio with purpose.
The Aptus portfolio includes established product brands across its pharmaceutical business.
Pharma formulations and prescription brands


















OTC & wellness brands






A clearer view for investors.
Stay informed with Aptus’ financial reports, investor presentations, regulatory disclosures and shareholder resources.
Beyond the numbers.
Stay connected with the latest from Aptus — company updates, announcements, media coverage and stories that reflect our journey.
Visit the news archiveCompany updates
Announcements, milestones and developments from Aptus.
Media & stories
Selected news, features and coverage from across the media.
Giving back to society
Beyond business, serving humanity.
Leader vision
At Aptus Pharma Limited, our vision is to build a future where quality healthcare solutions are accessible, reliable, and driven by innovation. We aspire to be a globally trusted pharmaceutical organization, recognized for excellence, integrity, and sustainable growth.
Our focus is on continuously strengthening our capabilities, embracing innovation, and setting new benchmarks in pharmaceutical excellence. Through a commitment to quality and responsible progress, we aim to create lasting value for patients, healthcare professionals, partners, and communities.
With a future-oriented mindset, we are dedicated to shaping a healthier tomorrow—where growth is aligned with purpose, progress is guided by responsibility, and success is measured by the positive impact we create.
Driven by purpose. Defined by quality. Focused on the future.
Mr. Tejash Hathi
Managing Director, Aptus Pharma Limited
Read the latest management commentaryFor business enquiries, click on 'Contact us' button on the right. For job related query click on 'Careers' in the footer below.